Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Completed
- Conditions
- Ankylosing Spondylitis
- Registration Number
- NCT00227227
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Brief Summary
The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 750
Inclusion Criteria
- Diagnosis of ankylosing spondylitis
Exclusion Criteria
- Contraindications according SmPC
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method